Product identification
Medicine name:
Nobivac Respira Bb vet. suspension for injection in pre-filled syringe for dogs
Nobivac Respira Bb suspensija injekcijām pilnšļircē suņiem
Active substance:
- Bordetella bronchiseptica, strain Bb7 92932, fimbriae
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Bordetella bronchiseptica, strain Bb7 92932, fimbriae88.00enzyme-linked immunosorbent assay unit1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection in pre-filled syringe
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI06AE02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Manufacturing sites for batch release:
- Intervet International B.V.
Authorisation number:
- V/DCP/20/0055
Date of authorisation status change:
Reference member state:
-
Denmark
Procedure number:
- DK/V/0123/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 31/01/2025
PI.pdf
English (PDF)
Download Published on: 27/01/2022
How useful was this page?: